Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperidone for Anxiety in Bipolar Disorder
NCT00167479Phase 4Completed
- Sponsor
- University of South Florida
- Start
- Sep 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of risperidone in bipolar disorder (BD), panic disorder, generalized anxiety disorder (GAD), sponsored by University of South Florida. Started Sep 2003; status: completed.
02
Drugs
risperidone
03
Conditions
bipolar disorder (BD)panic disordergeneralized anxiety disorder (GAD)
Beyond the preview
Go deeper on NCT00167479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00167479.